Cargando…

Uptake Rates of Risk-Reducing Surgeries for Women at Increased Risk of Hereditary Breast and Ovarian Cancer Applied to Cost-Effectiveness Analyses: A Scoping Systematic Review

SIMPLE SUMMARY: For women who have tested positive for BRCA mutations, the decision to make use of preventive surgical options, such as risk-reducing mastectomy (RRM) or risk-reducing bilateral salpingo-oophorectomy (RRSO), depends on the women’s personal preferences and the cultural/social context....

Descripción completa

Detalles Bibliográficos
Autores principales: Simões Corrêa Galendi, Julia, Kautz-Freimuth, Sibylle, Stock, Stephanie, Müller, Dirk
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8997187/
https://www.ncbi.nlm.nih.gov/pubmed/35406563
http://dx.doi.org/10.3390/cancers14071786
_version_ 1784684648162394112
author Simões Corrêa Galendi, Julia
Kautz-Freimuth, Sibylle
Stock, Stephanie
Müller, Dirk
author_facet Simões Corrêa Galendi, Julia
Kautz-Freimuth, Sibylle
Stock, Stephanie
Müller, Dirk
author_sort Simões Corrêa Galendi, Julia
collection PubMed
description SIMPLE SUMMARY: For women who have tested positive for BRCA mutations, the decision to make use of preventive surgical options, such as risk-reducing mastectomy (RRM) or risk-reducing bilateral salpingo-oophorectomy (RRSO), depends on the women’s personal preferences and the cultural/social context. Among others, the cost-effectiveness of RRM and RRSO can be affected by the uptake rate of these preventive surgical options. Uptake rates of surgery should be given more attention in the conceptualization of health economic modeling studies for RRM and RRSO. Prospective multicenter studies are recommended to reflect regional and national variations in women’s preferences for preventive surgery. ABSTRACT: The cost-effectiveness of genetic screen-and-treat strategies for women at increased risk for breast and ovarian cancer often depends on the women’s willingness to make use of risk-reducing mastectomy (RRM) or salpingo-oophorectomy (RRSO). To explore the uptake rates of RRM and RRSO applied in health economic modeling studies and the impact of uptake rates on the incremental cost-effectiveness ratios (ICER), we conducted a scoping literature review. In addition, using our own model, we conducted a value of information (VOI) analysis. Among the 19 models included in the review, the uptake rates of RRM ranged from 6% to 47% (RRSO: 10% to 88%). Fifty-seven percent of the models applied retrospective data obtained from registries, hospital records, or questionnaires. According to the models’ deterministic sensitivity analyses, there is a clear trend that a lower uptake rate increased the ICER and vice versa. Our VOI analysis showed high decision uncertainty associated with the uptake rates. In the future, uptake rates should be given more attention in the conceptualization of health economic modeling studies. Prospective studies are recommended to reflect regional and national variations in women’s preferences for preventive surgery.
format Online
Article
Text
id pubmed-8997187
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-89971872022-04-12 Uptake Rates of Risk-Reducing Surgeries for Women at Increased Risk of Hereditary Breast and Ovarian Cancer Applied to Cost-Effectiveness Analyses: A Scoping Systematic Review Simões Corrêa Galendi, Julia Kautz-Freimuth, Sibylle Stock, Stephanie Müller, Dirk Cancers (Basel) Systematic Review SIMPLE SUMMARY: For women who have tested positive for BRCA mutations, the decision to make use of preventive surgical options, such as risk-reducing mastectomy (RRM) or risk-reducing bilateral salpingo-oophorectomy (RRSO), depends on the women’s personal preferences and the cultural/social context. Among others, the cost-effectiveness of RRM and RRSO can be affected by the uptake rate of these preventive surgical options. Uptake rates of surgery should be given more attention in the conceptualization of health economic modeling studies for RRM and RRSO. Prospective multicenter studies are recommended to reflect regional and national variations in women’s preferences for preventive surgery. ABSTRACT: The cost-effectiveness of genetic screen-and-treat strategies for women at increased risk for breast and ovarian cancer often depends on the women’s willingness to make use of risk-reducing mastectomy (RRM) or salpingo-oophorectomy (RRSO). To explore the uptake rates of RRM and RRSO applied in health economic modeling studies and the impact of uptake rates on the incremental cost-effectiveness ratios (ICER), we conducted a scoping literature review. In addition, using our own model, we conducted a value of information (VOI) analysis. Among the 19 models included in the review, the uptake rates of RRM ranged from 6% to 47% (RRSO: 10% to 88%). Fifty-seven percent of the models applied retrospective data obtained from registries, hospital records, or questionnaires. According to the models’ deterministic sensitivity analyses, there is a clear trend that a lower uptake rate increased the ICER and vice versa. Our VOI analysis showed high decision uncertainty associated with the uptake rates. In the future, uptake rates should be given more attention in the conceptualization of health economic modeling studies. Prospective studies are recommended to reflect regional and national variations in women’s preferences for preventive surgery. MDPI 2022-03-31 /pmc/articles/PMC8997187/ /pubmed/35406563 http://dx.doi.org/10.3390/cancers14071786 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Systematic Review
Simões Corrêa Galendi, Julia
Kautz-Freimuth, Sibylle
Stock, Stephanie
Müller, Dirk
Uptake Rates of Risk-Reducing Surgeries for Women at Increased Risk of Hereditary Breast and Ovarian Cancer Applied to Cost-Effectiveness Analyses: A Scoping Systematic Review
title Uptake Rates of Risk-Reducing Surgeries for Women at Increased Risk of Hereditary Breast and Ovarian Cancer Applied to Cost-Effectiveness Analyses: A Scoping Systematic Review
title_full Uptake Rates of Risk-Reducing Surgeries for Women at Increased Risk of Hereditary Breast and Ovarian Cancer Applied to Cost-Effectiveness Analyses: A Scoping Systematic Review
title_fullStr Uptake Rates of Risk-Reducing Surgeries for Women at Increased Risk of Hereditary Breast and Ovarian Cancer Applied to Cost-Effectiveness Analyses: A Scoping Systematic Review
title_full_unstemmed Uptake Rates of Risk-Reducing Surgeries for Women at Increased Risk of Hereditary Breast and Ovarian Cancer Applied to Cost-Effectiveness Analyses: A Scoping Systematic Review
title_short Uptake Rates of Risk-Reducing Surgeries for Women at Increased Risk of Hereditary Breast and Ovarian Cancer Applied to Cost-Effectiveness Analyses: A Scoping Systematic Review
title_sort uptake rates of risk-reducing surgeries for women at increased risk of hereditary breast and ovarian cancer applied to cost-effectiveness analyses: a scoping systematic review
topic Systematic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8997187/
https://www.ncbi.nlm.nih.gov/pubmed/35406563
http://dx.doi.org/10.3390/cancers14071786
work_keys_str_mv AT simoescorreagalendijulia uptakeratesofriskreducingsurgeriesforwomenatincreasedriskofhereditarybreastandovariancancerappliedtocosteffectivenessanalysesascopingsystematicreview
AT kautzfreimuthsibylle uptakeratesofriskreducingsurgeriesforwomenatincreasedriskofhereditarybreastandovariancancerappliedtocosteffectivenessanalysesascopingsystematicreview
AT stockstephanie uptakeratesofriskreducingsurgeriesforwomenatincreasedriskofhereditarybreastandovariancancerappliedtocosteffectivenessanalysesascopingsystematicreview
AT mullerdirk uptakeratesofriskreducingsurgeriesforwomenatincreasedriskofhereditarybreastandovariancancerappliedtocosteffectivenessanalysesascopingsystematicreview